Pagani Isabel, Ghezzi Silvia, Alberti Simone, Poli Guido, Vicenzi Elisa
Viral Pathogenesis and Biosafety Unit, Division of Immunology, Transplantation, and Infectious Diseases, San Raffaele Scientific Institute, Via Olgettina, 58, Milan, Italy.
Human Immuno-Virology (H.I.V.) Unit, Division of Immunology, Transplantation, and Infectious Diseases, San Raffaele Scientific Institute, Via Olgettina, 58, Milan, Italy.
Eur Phys J Plus. 2023;138(2):157. doi: 10.1140/epjp/s13360-023-03719-6. Epub 2023 Feb 16.
SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS), has a zoonotic origin, although SARS-CoV-2 precise chain of animal-to-human transmission remains undefined. Unlike the 2002-2003 pandemic caused by SARS-CoV whose extinction from the human population was achieved in eight months, SARS-CoV-2 has been spreading globally in an immunologically naïve population in an unprecedented manner. The efficient infection and replication of SARS-CoV-2 has resulted in the emergence of viral variants that have become predominant posing concerns about their containment as they are more infectious with variable pathogenicity in respect to the original virus. Although vaccine availability is limiting severe disease and death caused by SARS-CoV-2 infection, its extinction is far to be close and predictable. In this regard, the emersion of the Omicron viral variant in November 2021 was characterized by humoral immune escape and it has reinforced the importance of the global monitoring of SARS-CoV-2 evolution. Given the importance of the SARS-CoV-2 zoonotic origin, it will also be crucial to monitor the animal-human interface to be better prepared to cope with future infections of pandemic potential.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新型冠状病毒,于2019年底在中国出现,引发了被称为2019冠状病毒病(COVID-19)的严重疾病。与之前具有高致病性的人类冠状病毒严重急性呼吸综合征冠状病毒(SARS-CoV,即严重急性呼吸综合征的病原体)一样,SARS-CoV-2也源自动物,但SARS-CoV-2的确切人畜传播链仍不明确。与2002 - 2003年由SARS-CoV引发的疫情在八个月内就从人类中消失不同,SARS-CoV-2以前所未有的方式在全球免疫原初人群中传播。SARS-CoV-2的有效感染和复制导致了病毒变体的出现,这些变体已成为主要毒株,由于它们比原始病毒更具传染性且致病性各异,因此对其控制构成了担忧。尽管疫苗的可及性限制了SARS-CoV-2感染导致的严重疾病和死亡,但要使其消失还远非近在咫尺且可预测。在这方面,2021年11月出现的奥密克戎病毒变体具有体液免疫逃逸的特征,这凸显了全球监测SARS-CoV-2进化的重要性。鉴于SARS-CoV-2人畜共患病起源的重要性,监测动物与人类的接触界面对于更好地应对未来具有大流行潜力的感染也至关重要。